Evidence map›Paper›PMID 42009823›Full record

SynthesisNature genetics2026

Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction.

Fei-Fei Cheng, Xiaoxi Liu, Hao Mi, Lizhong Wang, Ruilei Ma, Yazhou Guo, Julia Sidorenko, Chen Jiang, Tania Islam, Akira Meguro and 19 more

Erratum issuedAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Fei-Fei Cheng *New Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, China.
Xiaoxi Liu *Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Hao Mi *Chengdu 23Mofang Biotechnology Co. Ltd., Chengdu, China.
Lizhong Wang *WeGene, Shenzhen Zaozhidao Technology Co. Ltd., Shenzhen, China.ORCID http://orcid.org/0000-0002-3571-8771
Ruilei MaNew Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0002-2726-3834
Yazhou GuoNew Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0001-7942-5404
Julia SidorenkoInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-1494-6772
Chen JiangDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
Tania IslamBrain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Akira MeguroDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-9797-0948
Keiko HikinoThe Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0002-4852-2401
Yuki IshikawaLaboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0002-6514-8239
Senwei TangWeGene, Shenzhen Zaozhidao Technology Co. Ltd., Shenzhen, China.
Teng LiWeGene, Shenzhen Zaozhidao Technology Co. Ltd., Shenzhen, China.
Ruoyan ChenWeGene, Shenzhen Zaozhidao Technology Co. Ltd., Shenzhen, China.
Likun WangInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China.ORCID http://orcid.org/0000-0002-0933-2808
Reedik MägiEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-2964-6011
Andres MetspaluEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-3718-796X
Estonian Biobank Research Team
23andMe Research Team
Masaki TakeuchiDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-5494-0626
Nobuhisa MizukiDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0003-3738-8777
Hélène ChoquetDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.ORCID http://orcid.org/0000-0001-9839-8667
Zi-Bing JinBeijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Gang ChenWeGene, Shenzhen Zaozhidao Technology Co. Ltd., Shenzhen, China. cg@wegene.com.ORCID http://orcid.org/0000-0002-5808-0432
Kun ZhouChengdu 23Mofang Biotechnology Co. Ltd., Chengdu, China. kunbone@23mofang.com.ORCID http://orcid.org/0009-0000-8797-9431
Chikashi TeraoLaboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. chikashi.terao@riken.jp.ORCID http://orcid.org/0000-0002-6452-4095
Jian ZengInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. j.zeng@uq.edu.au.ORCID http://orcid.org/0000-0001-8801-5220
Jian YangNew Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, China. jian.yang@westlake.edu.cn.ORCID http://orcid.org/0000-0003-2001-2474

Funding

Wellcome Trust
6 · The paper itself

Abstract

Refractive errors (REs) affect over half of the global population, with consequences ranging from blurred vision to blindness. Here we conducted ancestry-stratified and cross-ancestry meta-analyses of genome-wide association studies for RE in people of European (n = 1,495,159), East Asian (n = 121,172) and African (n = 144,737) ancestries. The cross-ancestry meta-analysis identified 932 RE-associated variants, including 241 previously unknown associations, four East Asian-specific associations and one African-specific association. Statistical fine-mapping pinpointed 16 high-confidence putative causal variants, and gene prioritization analyses highlighted 23 genes involved in eye development. We constructed an enhanced polygenic predictor incorporating functional annotations that explained 21.4% of RE variation, effectively stratified the onset, progression and severity of myopia, and achieved an area under the receiver operating characteristic curve of 0.806 for predicting high myopia. Our multi-ancestry genome-wide association study expands substantially the catalog of genetic variants for RE and demonstrates the potential clinical utility of polygenic prediction in identifying high-risk people across diverse populations.

Indexed as

Genome-Wide Association StudyMultifactorial InheritanceRefractive ErrorsAfrican PeopleEast Asian PeopleEuropean PeopleGenetic Predisposition to DiseaseGenetic Risk ScoreHumansMyopiaPolymorphism, Single Nucleotide

Identifiers

PMID42009823
PMCPMC13175889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.